Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118Source: DataRank Database

Characterization of a new SARS-CoV-2 variant that emerged in Brazil is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 87 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access87 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.08)OA: hybridTopics (65)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (59)

Peter Halfmann ORCID,Seiya Yamayoshi ORCID,Kiyoko Iwatsuki‐Horimoto ORCID,S. Chiba ORCID,Tokiko Watanabe ORCID

Live enrichment

PubMed:34140350 PMC:PMC8271735 OpenAlex:https://openalex.org/W3168290720

NIAID NIH HHS

Grant: 75N93019C00051

NIAID NIH HHS

Grant: HHSN272201400008C

NIH HHS

Grant: P51 OD011106

National Institutes of Health

Grant: 3P51OD011106-60S1

Wisconsin National Primate Research Center Support

FWCI

5.08

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1073/pnas.2106535118

publisherhttps://doi.org/10.1073/pnas.2106535118

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2106535118

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34140350

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8271735

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingCOVID-19CricetinaeHumansImmunogenicity, VaccineLungMesocricetusMiceSARS-CoV-2Spike Glycoprotein, CoronavirusVirus ReplicationX-Ray Microtomography

MeSH Terms

Immunogenicity, VaccineCOVID-19SARS-CoV-2AnimalsCricetinaeHumansLungMesocricetusVirus ReplicationMiceX-Ray MicrotomographyAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

VirologyTiterSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyViral replicationRespiratory tractCoronavirusNeutralizationRespiratory systemImmunologyCoronavirus disease 2019 (COVID-19)VirusMedicineInfectious disease (medical specialty)DiseasePathologyreinfectionSyrian HamstersSars-cov-2P.1 VariantConvalescent Human PlasmaMesocricetusCOVID-19X-Ray MicrotomographyBiological SciencesVirus ReplicationAntibodies, NeutralizingMiceImmunogenicity, VaccineCricetinaeSpike Glycoprotein, CoronavirusAnimalsHumansLung

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being